Maria João Sousa

Oncology Institute of Coimbra, Coimbra, Portugal

About this speaker

The Speaker is updating their bio. Please check back here later.

Talks

Prognostic factors on her2-positive metastatic breast cancer patients treated with trastuzumab emtansine – real-world study

25 September 2021, 01:00 PM
Maria João Sousa